ARTICLE | Company News
Dr. Falk Pharma, Sigma-Tau S.p.A. deal
July 21, 2008 7:00 AM UTC
Sigma-Tau acquired Chenofalk chenodeoxycholic acid from Dr. Falk Pharma. Chenofalk is approved in Germany to treat gallstones and is used off-label to treat cerebrotendinous xanthomatosis (CTX) disea...